# Vaxcyte, Inc.: Form 8-K, filed Nov 28, 2023

- Company: [Vaxcyte, Inc.](/companies/pcvx.md) (CIK 1649094)
- Form: 8-K
- Filed: 2023-11-28
- Accepted by EDGAR: Nov 28, 2023, 08:32 ET
- Period: 2023-11-27
- Accession: 0001193125-23-283769
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1649094/000119312523283769/d604212d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1649094/000119312523283769/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1649094/000119312523283769/d604212d8k.htm

Filed Nov 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-283769. Last ingested by Listed: Nov 6, 2026, 13:09 ET. No prices; not investment advice.